Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
57.2M
-
Shares change
-
+9.49M
-
Total reported value, excl. options
-
$1.94B
-
Value change
-
+$286M
-
Put/Call ratio
-
0.14
-
Number of buys
-
100
-
Number of sells
-
-82
-
Price
-
$34.03
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q1 2020
238 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q1 2020.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.2M shares
.
Largest 10 shareholders include Capital International Investors (6M shares), BlackRock Inc. (3.27M shares), WELLINGTON MANAGEMENT GROUP LLP (3.12M shares), STIFEL FINANCIAL CORP (2.84M shares), MARSHALL WACE, LLP (2.56M shares), Capital World Investors (2.2M shares), RP Management, LLC (2.11M shares), STATE STREET CORP (1.98M shares), ORACLE INVESTMENT MANAGEMENT INC (1.87M shares), and EVENTIDE ASSET MANAGEMENT, LLC (1.78M shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.